United StatesBreaking News

Novo Nordisk (NYSE:NVO) announced that prescriptions for the oral version of Wegovy have exceeded 3 million since the product’s U.S. market introduction in January 2026.

Elon Musk wants to build the infrastructure for AI in space and he's asking investors to help pay for it. The rocket, satellite and now AI company wants to raise around 75 billion dollars in what could become the largest IPO in history, funding everything from its Starship rocket to AI computing power and future data centers in orbit. Bloomberg Tech's Ed Ludlow takes a look at what's at stake.

Johnson & Johnson (NYSE:JNJ) announced today that it has entered into a definitive agreement to acquire Firefly Bio for $1 billion in cash.

MetaVia (NASDAQ:MTVA) has reported new data from its cardiometabolic pipeline at the American Diabetes Association’s (ADA) 2026 Scientific Sessions in New Orleans.

Neurocrine Biosciences (NASDAQ:NBIX) has announced new clinician-reported data highlighting the effectiveness of INGREZZA (valbenazine) in treating tardive dyskinesia (TD) among individuals with intellectual and developmental disabilities (IDD).

Galmed Pharmaceuticals (NASDAQ:GLMD) has entered into a definitive agreement to acquire Colospan, a commercial-stage medical device company specializing in gastrointestinal surgery solutions.

Ingredion (NYSE:INGR) announced on Monday a definitive agreement to acquire the UK-based ingredients specialist Tate & Lyle in an all-cash transaction.

Alliance Resource Partners (NASDAQ:ARLP) announced on June 8, 2026, that it has entered into definitive agreements to acquire general partner and limited partner interests in AllDale Minerals III, LP and AllDale Minerals IV, LP (collectively, “AllDale III & IV”) for approximately $206.2 million.

FOX (NASDAQ:FOX) has finalized a multi-year agreement with the National Football League to serve as a broadcast partner for NFL content in Mexico.

Cameron Dawson, CIO at NewEdge Wealth, says semiconductor stocks are "nowhere near oversold" after last week's selloff.

Seaport Therapeutics (NASDAQ:SPTX) announced its financial results for the first quarter ended March 31, 2026, marking a pivotal period of transition for the Boston-based biotech as it enters the public markets.

Incyte (NASDAQ:INCY) announced today that it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, for an upfront payment of $1.25 billion.